OrbiMed executives acquire $499,984 worth of BiomX Inc. warrants

Executives from OrbiMed, a leading investment firm in the healthcare sector, have recently made significant purchases of derivative securities from BiomX Inc. (NYSE:PHGE), a company specializing in biological products. This move indicates a bolstered interest in the biotech firm\'s future potential. The transactions, which took place on March 15, 2024, involved OrbiMed Israel BioFund GP...

Read More